investordatabase.org

Invidia Capital Management, L.P.

invidiacap.com Direct investor

Invidia Capital Management is a healthcare-focused private equity firm that invests in middle-market companies across North America. It targets platform companies with EBITDA of $10–50 million and equity investments of $100–300 million.

Invidia Capital Management, L.P. is a private equity firm headquartered in New York, United States. It invests directly in companies, at buyout, in healthcare, pharma services, medtech services and HCIT. Its stated cheque size is $100-300mm. 2 portfolio companies, as it reports.

“Invidia is a healthcare-focused private equity firm investing in middle-market companies across North America.”

— Invidia Capital Management, L.P., own website
Layer
Direct investor
Type
Private equity
Stage
Buyout
Headquarters
New York, United States
Invests in
North America
Sectors
healthcare, pharma services, medtech services, HCIT, pharmacy services, multi-site providers, primary care, animal health
Cheque size
$100-300mm
Portfolio
2 companies
How to reach it
Its contact page on its own site

Team, as Invidia Capital Management, L.P. publishes it

  • Jo Natauri Founder and Managing Partner
  • Matt Bennett Partner
  • Shaunak Parikh Partner
  • Vince Cuticello CAO, General Counsel and CCO
  • Alice Kennon Head of Operations & Capital Formation
  • Jason Dunn Principal
  • Javier Bravo Nieto Vice President
  • Nicole Merken Senior Associate
  • Thomas Ryan Senior Associate
  • Bea Huffines Senior Associate
  • Kieran Storch Senior Associate
  • Stephanie Kline Executive Admin

Names and roles exactly as listed on invidiacap.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Invidia Capital Management, L.P. publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale?
— it reaches us directly, no email address to look up.

Record 21947 · added 2026-11-17 · link last verified 2026-11-17 · confidence high

Similar investors

Listed under